Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Net Income 2019–2025
Lyell Immunopharma, Inc. annual/quarterly net income history and growth rate from 2019 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Lyell Immunopharma, Inc. net income for the quarter ending March 31, 2026 was -24.2 M, a 53.73% decrease year-over-year.
- Lyell Immunopharma, Inc. net income for the twelve months ending March 31, 2026 was -157.9 M, a 21.81% decrease year-over-year.
- Lyell Immunopharma, Inc. annual net income for 2025 was -274.4 M, a 19.98% decrease from 2024.
- Lyell Immunopharma, Inc. annual net income for 2024 was -343.0 M, a 46.18% increase from 2023.
- Lyell Immunopharma, Inc. annual net income for 2023 was -234.6 M, a 28.13% increase from 2022.
- Lyell Immunopharma, Inc. annual net income for 2022 was -183.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lyell Immunopharma, Inc. Net Income — FAQ
Lyell Immunopharma, Inc. (LYEL) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Lyell Immunopharma, Inc.'s net income?
Lyell Immunopharma, Inc. (LYEL) reported net income of -$274M for fiscal 2025.
Where can I see LYEL's net income history?
The chart and table above show Lyell Immunopharma, Inc.'s net income by year and by quarter, including the growth rate.